Qiang Gao

Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine (CoronaVac) in healthy children and adolescents: a double-blind, randomised, controlled, phase 1/2 clinical trial

Bihua Han, Yufei Song, Changgui Li et al. · The Lancet Infectious Diseases · 2021 · 351 citations · Full text

Vaccination, Vaccine Safety, Vaccinology +8

Expression of matrix metalloproteinases-2 and -9 in intestinal tissue of patients with inflammatory bowel diseases

Qiang Gao, M. Meijer, F J G M Kubben et al. · Digestive and Liver Disease · 2005 · 136 citations

Inflammation, Chronic Inflammatory Diseases, Intestinal Tissue +10

Safety and immunogenicity of a novel human Enterovirus 71 (EV71) vaccine: A randomized, placebo-controlled, double-blind, Phase I clinical trial

Yanping Li, Zhenglun Liang, Qiang Gao et al. · Vaccine · 2012 · 93 citations

Vaccination, Vaccine Safety, Vaccine Development +7

Establishing China's national standards of antigen content and neutralizing antibody responses for evaluation of enterovirus 71 (EV71) vaccines

Zhenglun Liang, Qunying Mao, Qiang Gao et al. · Vaccine · 2011 · 74 citations · Full text

Vaccination, National Standards, Vaccine Development +15

Infliximab treatment influences the serological expression of matrix metalloproteinase (MMP)-2 and -9 in Crohnʼs disease

Qiang Gao, M. Meijer, Ulrike G. Schlüter et al. · Inflammatory Bowel Diseases · 2007 · 57 citations · Full text